K•REAL® GOLD

Enjoy the Benefits of Omega-3 Fatty Acids + MSO® 2.0

Introducing K•REAL® Gold. Produced using Enzymotec’s cutting-edge MSO® 2.0 technology, K•REAL® Gold now brings to the market an oil which contains higher levels of the beneficial omega-3 fatty acids, relative to previous generation products, while at the same time offering all the advantages of MSO® 2.0.

MSO-2_FLOWER-ICON

Breakthrough MSO® 2.0 Technology

Enzymotec has developed Multi-Stage Oil (MSO® 2.0) extraction, an innovative technology for the production of the
K•REAL® family of products. This specialized and proprietary MSO technology assures high-quality oil that has superior
organoleptic properties compared to other commercially available products, leading to an improved sense of purity,
potency, consistency and freshness when consuming the oil.

T-free 1,3

Low sodium

(according to EU regulation)

Resistance to oxidation 1,2

¹ These statements have not been evaluated/authorized by the Commission in accordance with Regulation (EC) 1924/2006 on
  nutrition and health claims made on foods.
² Results of levels of MDA from in-vitro stomach model, where krill oils of various producers were tested.
³ Limit of detection of both TVN, TMA and TMAO is 1mgN/100g. TVN, TMA and TMAO levels in krill oil samples were tested by an
  external laboratory, Nofima BioLab, Norway.Measurements were conducted in
  Conway dishes according to a modified version of Conway and Byrne’s micro-diffusion method (Conway & O’Malley, Microdiffusion
  Methods. Biochem, 36, 656-661(1942)).

K•REAL® Gold Claims

  • Qualified health claim approved by the FDA: "EPA and DHA omega-3 fatty acids may reduce the risk of coronary
    heart disease"
  • EFSA Claim (minimum daily dose of 1.04 gram): "EPA and DHA contribute to the normal function of the heart"
  • EFSA Claim: "Reducing consumption of sodium contributes to the maintenance of normal blood pressure"

Specifications

table

What’s in the K•REAL® Product Family?

Back to Top